1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Metaplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borchard, F; Hanisch, FG; Koldovsky, U | 1 |
1 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Metaplasia
Article | Year |
---|---|
Monoclonal antibody 2B5 defines a truncated O-glycan, GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-6 (GalNAc), on mucins from deep gastric and duodenal glands as well as metaplasia and neoplasia of gastric differentiation.
Topics: Animals; Antibodies, Monoclonal; Carbohydrate Sequence; Cell Differentiation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Duodenum; Enzyme-Linked Immunosorbent Assay; Gastric Juice; Gastric Mucosa; Glycolipids; Glycoproteins; Humans; Intestinal Mucosa; Metaplasia; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mucins; Oligosaccharides; Phosphatidylethanolamines; Stomach Neoplasms | 1993 |